The signaling properties and functions of protease-activated receptor (PAR)1 and PAR2 in cardiomyocytes

被引:0
|
作者
Sabri, A
Andrade-Gordon, P
Darrow, AL
Johnson, RW
Franke, TF
Steinberg, SF
机构
[1] Columbia Univ, New York, NY USA
[2] RW Johnson Pharmaceut Res Inst, Spring House, PA 19477 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
28
引用
收藏
页码:6 / 6
页数:1
相关论文
共 50 条
  • [31] Protease Activated Receptor 2 (PAR2): A Novel Regulator of Osteoclastogenesis
    Mcgrath, Sarah
    Hultin, Leif
    Lockhart, John C.
    Goodyear, Carl S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 379 - 380
  • [32] Pepducin - A Novel Protease-Activated Receptor-2 (par2) Inhibitor - Attenuates Experimental Pulmonary Hypertension
    Warburton, R.
    Kuliopulos, A.
    Wieschhaus, A.
    Kayyali, U. S.
    Toksoz, D.
    Fanburg, B. L.
    Preston, I. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [33] Protease-activated receptor 2 (PAR2)-targeting peptide derivatives for positron emission tomography (PET) imaging
    LeSarge, Jordan C.
    Thibeault, Pierre
    Yu, Lihai
    Childs, Marina D.
    Mirka, Victor M.
    Qi, Qi
    Fox, Matthew S.
    Kovacs, Michael S.
    Ramachandran, Rithwik
    Luyt, Leonard G.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 246
  • [34] Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) Pepducin
    Shearer, Andrew M.
    Rana, Rajashree
    Austin, Karyn
    Baleja, James D.
    Nguyen, Nga
    Bohm, Andrew
    Covic, Lidija
    Kuliopulos, Athan
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (44) : 23188 - 23198
  • [35] Signaling by protease-activated receptors PAR1 and PAR2 in smooth muscle reflects differential activation of G proteins:: GQ, GI and G12 by PAR1 and GQ, GI and G13 by PAR2
    Sriwai, Wimolpak
    Huang, Jiean
    Murthy, Karnam S.
    GASTROENTEROLOGY, 2006, 130 (04) : A144 - A144
  • [36] Profiling Gene Expression Induced by Protease-Activated Receptor 2 (PAR2) Activation in Human Kidney Cells
    Suen, Jacky Y.
    Gardiner, Brooke
    Grimmond, Sean
    Fairlie, David P.
    PLOS ONE, 2010, 5 (11):
  • [37] Agonists of protease-activated receptors (PAR1, PAR2 and PAR4) do not appear to be mediators of NANC contractions in rat bladder
    Long, JM
    Kaefer, M
    Packer, CS
    FASEB JOURNAL, 2004, 18 (05): : A1083 - A1083
  • [38] Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice
    Versteeg, Henri H.
    Schaffner, Florence
    Kerver, Marjolein
    Ellies, Lesley G.
    Andrade-Gordon, Patricia
    Mueller, Barbara M.
    Ruf, Wolfram
    CANCER RESEARCH, 2008, 68 (17) : 7219 - 7227
  • [39] Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists
    Hamilton, JR
    Frauman, AG
    Cocks, TM
    CIRCULATION RESEARCH, 2001, 89 (01) : 92 - 98
  • [40] PROTEASE ACTIVATED RECEPTOR 2 (PAR2)-MEDIATED ACTIVATION OF PROTEIN KINASE A
    Erb, Samuel J.
    Wang, Zaijie Jim
    FASEB JOURNAL, 2012, 26